IMPETIS BIOSCIENCES LTD has a total of 25 patent applications. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), Canada and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are PCT THERAPEUTICS INC, PHENEX PHARMACEUTICALS AG and GANGJEE ALEEM.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Canada | 3 | |
#3 | United States | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 2 | |
#6 | China | 2 | |
#7 | Israel | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Singapore | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Mookhtiar Kasim | 22 |
#2 | Basu Sujay | 16 |
#3 | Kulkarni Bheemashankar | 12 |
#4 | Thorat Sachin | 8 |
#5 | Patel Meena | 8 |
#6 | Shejul Yogesh | 8 |
#7 | Bonagiri Rajesh | 8 |
#8 | Khose Goraksha | 8 |
#9 | Meru Ashwin | 8 |
#10 | Panmand Anil | 8 |
Publication | Filing date | Title |
---|---|---|
AU2019205661A1 | Tricyclic compounds, compositions and medicinal applications thereof | |
US2020316077A1 | Pharmaceutical composition for the treatment of cancer | |
EP3596051A1 | Fused bicyclic compounds, compositions and applications thereof | |
EP3042903A1 | Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof | |
EP2402327A1 | Acetamide compounds as glucokinase activators, their process and medicinal applications |